The regulated binding of effector proteins to the nucleosome plays a central role in the activation and silencing of eukaryotic genes. How this binding changes the properties of chromatin to mediate gene activation or silencing is not fully understood. Here we provide evidence that association of the budding yeast silent information regulator 3 (Sir3) silencing protein with the nucleosome induces a conformational change in the amino terminus of histone H4 that promotes interactions between the conserved H4 arginines 17 and 19 (R17 and R19) and nucleosomal DNA. Substitutions of H4R17 and R19 with alanine abolish silencing in vivo, but have little or no effect on binding of Sir3 to nucleosomes or histone H4 peptides in vitro. Furthermore, in both the previously reported crystal structure of the Sir3-bromo adjacent homology (BAH) domain bound to the Xenopus laevis nucleosome core particle and the crystal structure of the Sir3-BAH domain bound to the yeast nucleosome core particle described here, H4R17 and R19 make contacts with nucleosomal DNA rather than with Sir3. These results suggest that Sir3 binding generates a more stable nucleosome by clamping H4R17 and R19 to nucleosomal DNA, and raise the possibility that such induced changes in histone-DNA contacts play major roles in the regulation of chromatin structure.
The regulated binding of effector proteins to the nucleosome plays a central role in the activation and silencing of eukaryotic genes. How this binding changes the properties of chromatin to mediate gene activation or silencing is not fully understood. Here we provide evidence that association of the budding yeast silent information regulator 3 (Sir3) silencing protein with the nucleosome induces a conformational change in the amino terminus of histone H4 that promotes interactions between the conserved H4 arginines 17 and 19 (R17 and R19) and nucleosomal DNA. Substitutions of H4R17 and R19 with alanine abolish silencing in vivo, but have little or no effect on binding of Sir3 to nucleosomes or histone H4 peptides in vitro. Furthermore, in both the previously reported crystal structure of the Sir3-bromo adjacent homology (BAH) domain bound to the Xenopus laevis nucleosome core particle and the crystal structure of the Sir3-BAH domain bound to the yeast nucleosome core particle described here, H4R17 and R19 make contacts with nucleosomal DNA rather than with Sir3. These results suggest that Sir3 binding generates a more stable nucleosome by clamping H4R17 and R19 to nucleosomal DNA, and raise the possibility that such induced changes in histone-DNA contacts play major roles in the regulation of chromatin structure.
gene silencing | histone H4 tail A ssembly of eukaryotic DNA into chromatin plays a central role in the regulation of gene expression and genome stability. The fundamental unit of chromatin folding, the nucleosome, is composed of 147 bp of DNA wrapped twice around an octamer of histones H2A, H2B, H3, and H4 (1) . Posttranslational modifications of histones play important roles in the regulation of chromatin structure by affecting the interaction of histones with nucleosomal DNA and by recruiting effector molecules that perform downstream functions (2) (3) (4) (5) (6) . Although many different types of chromatin domains have been defined based on histone modification patterns (7), the active gene-rich and inactive, repetitive, gene-poor chromosome regions are commonly referred to as euchromatin and heterochromatin, respectively.
In the budding yeast Saccharomyces cerevisiae, the silent mating type cassettes and telomeric DNA regions are assembled into heterochromatin-like structures that display epigenetic inheritance patterns and regional effects on gene expression (8) (9) (10) . Studies by Grunstein and coworkers (11, 12) provided the first evidence of a specific role for histones in silencing. The conserved amino terminus of histone H4 is dispensable for growth but is required for repression of the silent mating type loci (11, 12) . In the H4 amino terminus, substitutions within a basic patch region, composed of lysine 16 (K16), arginine 17 (R17), histidine 18 (H18), and arginine 19 (R19), abolish silencing, whereas substitution of lysine 20 (K20) has a partial silencing defect (12) . Furthermore, H4K16 is hypoacetylated within silent domains, and although its substitution to arginine is tolerated, substitutions to alanine and glutamine abolish silencing, providing evidence that H4K16 acetylation regulates silencing in vivo (12, 13) . In addition to histone H4, the globular domain of histone H3 surrounding lysine 79 (K79), termed the loss of rDNA silencing (LRS) surface, is required for silencing (14-17).
The establishment and maintenance of silent domains at telomeres and the mating type loci also requires the silent information regulator (Sir) 2, 3, and 4 proteins (18, 19) . The Sir2 and Sir4 proteins form a subcomplex that associates with Sir3 into the silent infomation regulator (SIR) complex (20) (21) (22) (23) . Sir2 is a NAD-dependent deacetylase with preference for H4K16 (24) (25) (26) , whereas Sir3 is a histone H4 and nucleosome binding protein that displays a strong preference for histone H4 peptides and nucleosomes that contain unacetylated H4K16 (22, 27, 28) . The association of Sir3 with chromatin is also inhibited by dimethylation or trimethylation of histone H3K79 (29, 30) occurring in transcribed genomic regions (14, 16) .
Sir3 associates with nucleosomes via a conserved N-terminal domain, the bromo adjacent homoloy (BAH) domain, as well as a less well-characterized C-terminal domain with similarities to AAA ATPases (AAL domain) but lacking ATP binding or hydrolysis activity (27, 29, (31) (32) (33) . The recently solved 3-Å resolution crystal structure of the BAH-nucleosome complex reveals how the BAH domain binds to the nucleosome and how this binding is controlled by acetylation and methylation (34) . H4K16 and H18 make multiple hydrogen-bonding interactions with a deep pocket in the BAH domain, which would be disrupted by acetylation of the H4K16 epsilon amino group. The importance of this BAH binding pocket is supported by studies indicating that mutations within the binding pocket and surrounding residues disrupt silencing in vivo (32, 33, 35) . The H4 tail exits the nucleosome near the LRS regions, and within this region, H3K79 and its surrounding residues also have multiple bonding interactions with the BAH domain (34) . Thus, although the BAH-nucleosome structure provides clear evidence of the participation of H3K79, H4K16, and H4H18 in Sir3-nucleosome binding, it does not address how this binding mediates the silencing function of Sir3. In particular, the roles of H4R17 and R19, two residues in the basic patch region that are as critical for silencing as H4K16 (12) , remain unclear.
In this study, we examined the roles of amino acids in the histone H4 basic patch in histone peptide and nucleosome binding. As expected, we found that substitutions of H4K16 and H18 with alanine abolished histone H4 peptide and nucleosome binding.
However, substitutions of H4R17 and R19, which disrupted silencing to the same extent as K16 or H18 substitutions, had no effect on Sir3 binding in our in vitro assays. Consistent with the biochemical binding data, both H4R17 and R19 point away from the BAH domain in the crystal structure of the BAH domain in complex with the yeast nucleosome core particle (reported here), as well as the BAH domain in complex with the Xenopus laevis nucleosome core particle reported by Armache et al. (34) . Rather than making contact with the BAH domain, these arginines make contacts with phosphates in the nucleosomal DNA backbone. Based on the foregoing findings, we propose that binding of Sir3 to the nucleosome induces a conformational change that clamps H4R17 and R19 onto nucleosomal DNA to create a silenced nucleosome.
Results and Discussion
We used a pull-down assay that examines the association of nucleosomes from a solubilized chromatin extract with tandem affinity purification (TAP)-tagged Sir3 to determine the contribution of H4R17, R19, and other amino acids in the H4 basic patch region to the binding of Sir3 to nucleosomes ( Fig. 1A; see Tables S1 and S2 for yeast strains and plasmids). As a control and consistent with previous results (29) , the substitution of H4K16 with either glutamine or alanine (H4K16Q and K16A, respectively) abolished the association of nucleosomes with Sir3 (Fig. 1B , compare lanes 10, 15, and 16; Fig. S1 ). Similarly, consistent with its interaction with the BAH domain (34) , the substitution of H4H18 with alanine (H4H18A) abolished the binding of nucleosomes to Sir3 (Fig. 2B , compare lanes 10 and 13). In contrast, the substitution of either H4R17 or R19 with alanine (H4R17A and R19A, respectively) resulted in increased binding of nucleosomes to Sir3 (Fig. 1B , compare lanes 10, 12, and 14). As further controls, substitutions at H4K20 and K56 (H4K20A and K56A, respectively), which have weak silencing defects, had no effect on the Sir3-nucleosome interaction in this assay (Fig. 1B, lanes 11 and 17) .
We next tested the importance of the H4 basic patch residues in Sir3 binding using a biotinylated peptide pull-down assay. Consistent with the nucleosome binding data, the acetylation of H4K16 (H4K16Ac) or the substitution of H4H18 with alanine diminished the ability of these residues to bind to either fulllength Sir3 or the BAH domain (Fig. 1C , compare lanes 3, 4, and 6; Fig. 1D , lanes 6 and 7). On the other hand, the substitution of either H4R17 or R19 with alanine had little or no effect on the binding of full-length Sir3 or the BAH domain (Fig. 1C , compare lanes 3, 5, and 7). Thus, H4R17 and R19 are not required for the association of Sir3 with either nucleosomes or histone H4 N-terminal peptides.
Consistent with previous nucleosome-binding studies (29) and extensive contacts between the BAH domain and H3K79 (34), trimethylation of H3K79 abolished the binding of full-length Sir3 and the BAH domain to a peptide spanning amino acids 67-89 of histone H3 (Fig. 1D, lanes 3 and 4) . Moreover, consistent with nucleosome-binding results (28) , the substitution of H3K79 with alanine had no effect on binding (Fig. 1D, lane 5 ). This suggests that the methylation of H3K79 by Dot1 inhibits Sir3 binding via a steric hindrance mechanism that prevents interactions between Sir3 and the surrounding LRS region, rather than with H3K79 itself.
To verify that the point mutations used in our studies had the expected loss of silencing defects, we performed quantitative RT-PCR (qRT-PCR) to measure RNA levels for the subtelomeric YFR057w open reading frame on the right arm of chromosome VI, which is silenced in a Sir3-dependent manner. Substitutions of R17 and R19 with alanine displayed a similar increase in YFR057w RNA levels as seen with substitutions of H4K16 and H18, which are Sir3-contacting amino acids (Fig. 1E) . However, ChIP experiments showed that H4R17A and R19A mutations disrupted the association of Sir3 with YFR057w in vivo (Fig. S2) , likely owing to disruption of the Sir3-nucleosome interaction in cells carrying the arginine mutations during chromatin remodeling and transcription activation.
We note that the basic patch region of H4 also provides a binding site for the H3K79 methyltransferase disruptor of telomeric silencing 1 (Dot1), an event required for efficient silencing (30, 36) . However, the complete loss of Dot1-mediated H3K79 methylation requires substitutions of both H4R17 and R19 with alanine (30, 36) , and dot1Δ cells have near-WT silencing at the homothalic left (HML) mating type locus (37, 38) , whereas the substitution of either H4R17 or R19 results in loss of silencing at HML and subtelomeric regions (12) (Fig. 1E) . Thus, the silencing defects of H4R17 and R19 cannot be explained by a loss of Dot1 binding. In fact, the increase in Sir3 binding in the H4R17A and R19A mutations noted above (Fig. 1B) is similar to what we had previously observed comparing WT with Δdot1 cells using the same nucleosome pull-down assay (29) , and suggests that increased Sir3 binding results from weaker Dot1 binding to the H4 basic patch region and reduced H3K79 methylation.
The crystal structure of the BAH domain (Sir3 amino acids 1-214) in complex with the heterologous X. laevis nucleosome core particle suggests that H4R17 and R19 do not contact the BAH domain (34) . To determine whether these arginines occupy similar positions when the BAH domain is bound to the yeast nucleosome, we solved the crystal structure of a Sir3 N-terminal fragment from amino acids 2-382 (Sir3-382), which included the conserved BAH domain, in complex with the nucleosome core particle (NCP), reconstituted using the 147-bp Widom 601 positioning DNA and bacterially produced yeast histones. We used the Sir3-382 protein because it binds to the nucleosome with greater affinity than the smaller BAH domain (Sir3-214), and its binding is sensitive to substitutions at either H4K16 or H3K79 (Figs. S1 and S3). We further introduced a point mutation at position 205 (E205N), which was previously shown to increase the affinity of Sir3 for the nucleosome (34, 39) . The 3.1-Å resolution structure of Sir3-382-ScNCP shows two BAH domains bound symmetrically to each side of the nucleosome ( Fig. 2A and Table S3 ). Most of the Sir3-nucleosome interaction interface in our structure was identical to the Sir3-214-XlNCP complex (34) (Fig. S4) , showing extensive contacts between the BAH domain and the globular domain of histone H3 surrounding H3K79 and the amino terminus of histone H4. Amino acids 216-382, beyond the BAH domain, displayed discontinuous electron density, which is consistent with predictions that this low-complexity region is unstructured, and are not presented in the structure.
We observed clear electron density for the H4R19 side chain and weaker electron density for the H4R17 side chain, but both arginines clearly pointed away from the BAH domain and were in a position to make contact with DNA ( Fig. 2 A and B) . H4R19 was located in a similar position as that previously described for the Sir3-214-XlNCP structure (Fig. 2C) . However, whereas in the Sir3-214-XlNCP structure, both arginines were located close to the phosphate of nucleotide 100, in the Sir3-382-ScNCP structure, H4R17 was located closer to the phosphate of nucleotide 52 ( Fig. 2 C and D) . Thus, H4R17 and R19 interact with phosphates 100 and 52, respectively, which are located across the minor groove on opposite strands of the DNA double helix in the BAH-nucleosome complex (Fig. 2 C and D) . The different positions of H4R17 in the two structures may be related to alternative conformations or flexibility of R17, the location of which may be stabilized by additional Sir3 sequences or the other subunits of the SIR complex. Unlike H4K16 and H18, which penetrate binding pockets in the BAH domain, H4R17 and R19 make salt bridges with phosphates of nucleosomal DNA (Fig. 2D) . Nucleotides 52 and 100, which contact H4R17 and R19, respectively, are located on complementary strands across the DNA minor groove (Fig. 2D) . In addition, the contacts are symmetrical for the two histone H4 chains (Fig. S5 A and B) . Thus, the locations of H4R17 and R19 in BAH complexes with yeast and frog nucleosomes are consistent, and support the idea that the silencing function of these amino acids involves their interaction with nucleosomal DNA rather than with Sir3. To determine whether silencing requires H4R17 and R19 under conditions in which Sir3 is present on chromatin, we took advantage of the observation that overexpressed Sir3 associates with the HML locus and silences the expression of the α1 and α2 genes even in sir4I1311N mutant cells, in which it cannot interact with the Sir2/Sir4 deacetylase complex (Fig. S2 ). This silencing is not accompanied by the spread of the Sir2/Sir4 deacetylase and requires the substitution of H4K16 with arginine (H4K16R), which mimics deacetylated lysine. To determine whether the silencing mediated by this Sir3 binding requires H4R17 or R19, we constructed Sir3-overexpressing (SIR3OE) cells with H4R17A and R19A substitutions alone or in combination with H4K16R substitutions. Sir3 bound to the HML locus at near-WT levels in H4R17A and R19A cells, but this binding did not correlate with silencing of the α1 and α2 genes (Fig. S2 B and C) . Furthermore, no silencing was observed even in cells in which the foregoing mutations were combined with H4K16R, indicating that the roles of H4R17 and R19 in silencing did not involve a contribution to the binding of overexpressed Sir3 or K16 deacetylation (Fig. S2  B and C) . We emphasize that, as shown in Fig. S2A for the subtelomeric YFR057W gene, in the absence of overexpression, the H4R17A and R19A mutations disrupted Sir3 binding to chromatin, suggesting that even though they are not Sir3 contact residues, H4R17 and R19 affect the stability of Sir3 on chromatin in vivo.
Taken together, the biochemical and structural evidence presented here indicate that H4R17 and R19 play a role in silencing that is distinct from the role of H4K16 and H18. Histone tails generally display relatively weak electron density in the crystal structures of free nucleosomes reported to date (for examples, see refs. 1 and 40). Nonetheless, the conformation of the H4 tail and H4R17 and R19 observed in the Sir3-NCP complexes are unique. Comparison of the H4 tail conformation in the free yeast nucleosome (40) and the Sir3-382-ScNCP complex indicates that the association of Sir3 with the nucleosome results in a conformational change in the H4 N-terminal tail involving a rotation around the main chain of asparagine 25 ( Fig. 3 A-C) . This rotation allows H4K16, H18, K20, L22, and R23 to interact with the BAH domain and brings the R17 and R19 side chains in close proximity to nucleosomal DNA. The locations of the R17 and R19 side chains may be further constrained by interactions of their backbone carbonyl groups with E137 in the BAH domain ( Fig. 2B and Fig. S6 ). We propose that the salt bridges between these H4 arginines and the phosphates in the DNA backbone clamp the nucleosomal DNA to the histone octamer and help create a "silenced nucleosome" (Fig. 3D) . This silenced nucleosome is likely to be more resistant to unwinding by chromatin remodeling complexes, a required step for DNA accessibility and transcription. The H4 amino terminus is likely to interact with nucleosomal DNA even in the absence of Sir3, such as in the high-resolution Xenopus nucleosome crystal structure (Fig. S4 B-D) (41) . Previous studies have suggested that interactions between histone tails and DNA contribute to nucleosome stability and are regulated by acetylation (42) . Thus, Sir3 may shift the equilibrium toward a conformation that has evolved to contribute to nucleosome stability.
Our findings suggest that silencing requires a specific mode of Sir3-nucleosome association and provide a possible explanation for previous reports suggesting that SIR complex binding does not correlate with silencing (28, 43, 44) . The formation of a silenced nucleosome most likely requires multiple bonding interactions between Sir3 and the nucleosome that together stably clamp nucleosomal DNA to the histone octamer. The loss of a subset of the bonding interactions may allow for a more dynamic form of Sir3 binding that is insufficient to silence transcription. The functions of H4R17 and R19 proposed herein are reminiscent of the histone sin mutations that suppress defects in chromatin remodeling (45, 46) . A large fraction of these mutations affect the interaction of histone H4R45 with a minor groove in nucleosomal DNA (46) , providing another example of profound effects on chromatin structure resulting from histone point mutations that affect contacts with DNA.
Materials and Methods
Protein Expression and Purification. A DNA fragment encoding residues 2-382 of Sir3 was cloned into a modified pET28b vector with a His 6 -Sumo tag fused at the N terminus. The D205N point mutation was introduced using the QuikChange II Site-Directed Mutagenesis Kit (Agilent). The Sir3 (2-382, D205N (IPTG) at 25°C, the cells were harvested by centrifugation, and the resulting pellet was resuspended in lysis buffer [50 mM Tris·HCl (pH 8.0), 50 mM NaH 2 PO 4 , 400 mM NaCl, 3 mM imidazole, 10% glycerol, 1 mM PMSF, 0.1 mg/ mL lysozyme, 2 mM 2-mercaptoethanol, and complete protease inhibitor mixture tablets (Roche)]. The cells were then lysed by sonication, and the cell debris was removed by ultracentrifugation. The supernatant was mixed with Ni-nitriloacetic acid (NTA) agarose beads (Qiagen) and rocked for 4 h at 4°C, then washed twice with 20 column volumes of 10 mM imidazole in lysis buffer before elution with 250 mM imidazole. The ubiquitin-like specific protease 1 (ULP1) protease was added to remove the His 6 -Sumo tag. Finally, the protein was further purified by passage through a Mono-Q ionexchange column (GE Healthcare) and by gel-filtration chromatography on a Hiload Superdex 75 (GE Healthcare) equilibrated with 25 mM Tris·HCl (pH 8.0), 150 mM NaCl, and 5 mM DTT. The purified Sir3 (2-382, D205N) protein was concentrated to 25 mg/mL using centrifugal filters (Millipore) and stored at −80°C. Budding yeast S. cerevisiae histones H2A, H2B, H3, and H4 were expressed in E. coli; purified; renatured in 2 M NaCl; and assembled into octamers through stepwise salt dialysis. The histone octamer core was assembled with the 601 Widom positioning sequence into the nucleosome core particle as described previously (1).
Sir3-NCP Complex Preparation and Crystallization. The complex of the Sir3-382 and the nucleosome core particle was assembled by mixing the Sir3 protein with nucleosome core particle in a 2:1 molar ratio before a final size-exclusion chromatography step (Superose 6; GE Healthcare). The assembled complex was concentrated to 8 mg/mL for crystallization screening trials. The crystals were grown by sitting drop vapor diffusion in 0.05 M sodium cacodylate (pH 7.5) and 32% (vol/vol) 2-methyl-2,4-pentanediol (MPD) at 4°C. Crystals were transferred to 40% (vol/vol) MPD in 1% increments with 10 min between each step, and then flash-frozen in liquid nitrogen.
Data Collection and Crystallographic Analysis. Diffraction data were collected at the Advance Photon Source The Northeastern Collaborative Access Team (NE-CAT) beamline 24-ID-C, and processed using XDS and the CCP4 package (47, 48) . The structure was solved by molecular replacement using Phaser (49) , and a search model containing the budding yeast histone octamer core and the 147-bp human α-satellite DNA (PDB ID code 1ID3), with the DNA bases manually changed to the 601 Widom sequence. A clearly positive density for Sir3-382 was present on both sides of the nucleosome in the difference electron density map. Crystallographic refinement was carried out using PHENIX with manual model building in Coot (50, 51) . All graphic presentations were prepared in PyMOL (www.pymol.org/). Secondary structural prediction was performed using the PredictProtein server (www. predictprotein.org).
Yeast Strains and Protein Purification. The strains and plasmids used in this study are listed in Tables S1 and S2 . Yeast strains were made by a PCR-based gene targeting procedure (52) (53) (54) (55) . Histone mutant strains were constructed by introducing individual histone mutations by plasmid shuffle into the background strain of DMY3903 or DMY3985, as described previously (12, 56) . Plasmids carrying histone mutations were kindly provided by Dr. Jef Boeke (57) and Dr. Sharon Dent (56) . FLAG-tagged Sir3 proteins expressed in yeast were purified as described previously (22, 35) .
TAP Protein Purification and Western Blot Analysis. TAP-pull downs were performed as described previously (29, 55) . In brief, cells were resuspended in equal volumes of lysis buffer [50 mM Hepes KOH (pH 7.6), 10 mM magnesium acetate; 5 mM EGTA, 0.1 mM EDTA, 150 mM potassium chloride, 0.2% Nonidet P-40, 5% glycerol, 2 mM phenylmethylsulfonylfluoride, 1 mM benzamidine, and 1 mg/mL each leupeptin, bestatin, and pepstatin] and lysed by bead beating. The resulting lysate was incubated with IgG-coupled M-270 Dynabeads (Invitrogen) for 90-120 min at 4°C. Beads were washed four times with lysis buffer and resuspended in SDS sample buffer. Samples were loaded on SDS/PAGE, transferred to nitrocellulose membranes, and probed with peroxidase anti-peroxidase (Sigma-Aldrich) and anti-H3 (Abcam) antibodies.
Quantitative RT-PCR. Yeast cultures were grown in yeast extract peptone dextrose (YEPD) medium at 30°C to an OD 600 of 0.5. Total RNA was isolated by the hot phenol procedure and cleaned using the RNeasy Kit (Qiagen) to remove potential genomic DNA contamination. Gene-specific primers for YFR057W were used to prepare cDNA, followed by quantitative PCR using a LightCycler (Applied Biosystems). Relative RNA levels were calculated from CT values according to the ΔCT method and normalized to act1 + RNA levels.
Native Gel Shift and Peptide Pull-Down Assays. Mononucleosomes were reconstituted as described previously (1, 28) . Increasing molar ratios of full-length Sir3 protein or its subdomains were incubated with 8 nM mononucleosome, assembled on a 218-bp DNA fragment containing the 601 Widom positioning sequence (58) in binding buffer containing 20 mM Hepes (pH 7.5), 4 mM Tris (pH 7.5), 80 mM KCl, 0.1% Nonidet P-40, 0.2 mM EDTA, 2 mM DTT, 0.5 mg/ mL BSA, and 5% glycerol. The binding reaction was carried out at 30°C for 1 h, followed by chilling on ice for 15-20 min before loading onto the 3.5% native polyacrylamide gel. The native polyacrylamide gel was prerun at 50V for 1 h in 0.25× tris-borate EDTA (TBE), and then changed with fresh 0.25× TBE buffer. Samples were separated at 100V for 1.5-2 h at 4°C or for 4-4.5 h in the presence of antibody. The gel was dried, analyzed by a storage phosphor screen, and quantified with Quantity One software (Bio-Rad). Saturation curves were analyzed using Kaleidograph software (Synergy Software). Peptide pull-down assays were carried out by incubating 1 μg of biotinylated histone peptides with Sir3 protein in 25 mM Hepes (pH 7.5), 150 mM NaCl, 10% glycerol, 100 μg/mL BSA, 0.5 mM DTT, 0.1% Tween-20, and 1 μg/mL leupeptin, pepstatin, and aprotinin for 1 h at room temperature in a rotary shaker. Peptides were then isolated with magnetic streptavidin beads for 30 min at room temperature. Beads were resuspended in SDS sample buffer and loaded onto 12% SDS/PAGE, followed by Western blot analysis with anti-Flag antibody. of histone plasmids; and Dr. Piotrek Sliz and the staff of the SBGrid Consortium and Drs. J. Schuermann, F. Murphy, S. Banerjee, K. Perry, and the staff of the NE-CAT Argonne National Laboratory for assistance with data collection and processing. This work was supported by the National Institutes of Health (Grant GM GM61641, to D.M., and Pathway to Independence Award GM094291, to A.J. 
